Achieve Life Sciences (ACHV) Retained Earnings (2010 - 2026)
Achieve Life Sciences (ACHV) recorded quarterly Retained Earnings of -$270.4 million in Q1 2026, down 3.91% on a QoQ basis from -$260.2 million in Q4 2025, and down 23.81% year-over-year from -$354.9 million in Q1 2025.
Achieve Life Sciences (ACHV) Retained Earnings (2010 - 2026) Analysis & Trends
Achieve Life Sciences has disclosed Retained Earnings across 17 years of filings, most recently posting -$270.4 million for Q1 2026.
- Quarterly Retained Earnings fell 23.81% year-over-year to -$270.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$270.4 million (down 23.81% YoY) and the FY2025 annual result came in at -$260.2 million, down 26.58% from the prior year.
- Retained Earnings fell to -$270.4 million in Q1 2026, from -$260.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $3000.0 in Q2 2025 and troughed at -$270.4 million in Q1 2026.
- A 5-year average of -$167.3 million and a median of -$165.8 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 47.82% — and 2025, when it jumped 100.0%.
- Tracing ACHV's Retained Earnings over 5 years: stood at -$135.9 million in 2022, then retreated by 21.93% to -$165.8 million in 2023, then declined by 24.03% to -$205.6 million in 2024, then decreased by 26.58% to -$260.2 million in 2025, then dropped by 3.91% to -$270.4 million in 2026.
- Business Quant data shows ACHV's Retained Earnings at -$270.4 million in Q1 2026, -$260.2 million in Q4 2025, and -$245.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | -270.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -270.40 Mn |
| Dec 31, 2025 | -260.23 Mn |
| Sep 30, 2025 | -245.56 Mn |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | -218.41 Mn |
| Dec 31, 2024 | -205.58 Mn |
| Sep 30, 2024 | -193.20 Mn |
| Jun 30, 2024 | -180.71 Mn |
| Mar 31, 2024 | -172.25 Mn |
| Dec 31, 2023 | -165.75 Mn |
| Sep 30, 2023 | -160.28 Mn |
| Jun 30, 2023 | -153.20 Mn |
| Mar 31, 2023 | -144.93 Mn |
| Dec 31, 2022 | -135.94 Mn |
| Sep 30, 2022 | -124.70 Mn |
| Jun 30, 2022 | -111.63 Mn |
| Mar 31, 2022 | -101.16 Mn |
| Dec 31, 2021 | -93.59 Mn |
| Sep 30, 2021 | -86.44 Mn |
| Jun 30, 2021 | -79.70 Mn |